dacarbazine has been researched along with Chemotherapy-Induced Febrile Neutropenia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Advani, RH; Ansell, SM; Bartlett, NL; Chen, R; Connors, JM; Engley, G; Feldman, T; Fenton, K; Forero-Torres, A; Friedberg, JW; Gopal, AK; Gordon, LI; Kuruvilla, J; Manley, TJ; Ramchandren, R; Savage, KJ; Straus, DJ; Younes, A | 1 |
Buckstein, R; Chan, KK; Cheung, MC; Graczyk, J; Prica, A | 1 |
Chong, G; Doig, R; Grigg, A; Ha, FJ; Hamid, A; Hawkes, EA; Jalali, A; Mckendrick, J; Schwarer, AP | 1 |
1 trial(s) available for dacarbazine and Chemotherapy-Induced Febrile Neutropenia
Article | Year |
---|---|
Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Canada; Chemotherapy-Induced Febrile Neutropenia; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lung Injury; Male; Middle Aged; Neoplasm Staging; Peripheral Nervous System Diseases; Progression-Free Survival; United States; Vinblastine | 2019 |
2 other study(ies) available for dacarbazine and Chemotherapy-Induced Febrile Neutropenia
Article | Year |
---|---|
Granulocyte colony-stimulating factor in secondary prophylaxis for advanced-stage Hodgkin lymphoma treated with ABVD chemotherapy: a cost-effectiveness analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Canada; Chemotherapy-Induced Febrile Neutropenia; Cohort Studies; Cost-Benefit Analysis; Dacarbazine; Decision Support Systems, Clinical; Doxorubicin; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Markov Chains; Neoplasm Staging; Quality-Adjusted Life Years; Secondary Prevention; Treatment Outcome; Vinblastine | 2016 |
Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Australia; Bleomycin; Chemotherapy-Induced Febrile Neutropenia; Combined Modality Therapy; Dacarbazine; Databases, Factual; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lung Diseases; Male; Medical Records; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome; Vinblastine; Young Adult | 2016 |